PhRMA Submits Comments in Response to the NIH Office of Science Policy’s Request for Information on Draft NIH Intramural Research Program Policy

PhRMA recently submitted comments to the NIH Office of Science Policy's Request for Information on its Draft Intramural Research Program Policy: Promoting Equity Through Access Planning. PhRMA believes that federal investment in science and technology and attracting private sector investment to translate early research discoveries into innovative products is critically important for Americans and patients around the globe.